Search

everythinglearnresearchcommunity

for

Search:↓

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

A new hair loss treatment is being developed using reprogrammed stem cells to grow new hair follicles.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Early onset hair loss linked to genetics and androgen levels.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

There's no significant genetic link between male pattern baldness and COVID-19.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Higher testosterone harms sperm motility, while higher estradiol improves sperm survival.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Higher testosterone levels in Nigerian women with PCOS are linked to glucose disorders like diabetes.

High testosterone increases heart disease risk in women with PCOS.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Humans lost body hair relatively recently in evolution.

TSH is usually the only test needed to check thyroid function in primary care.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.